ArticleFrontiers in oncology2026

Intra- and peritumoral radiomics for predicting equivocal HER2 status of breast cancer on contrast-enhanced mammography.

Cong Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.